Discover a study that suggests that dual therapy could offer a safer and more effective approach to treating MASLD.

Galmed Pharmaceuticals Ltd. ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for the treatment of liver, cardiometabolic diseases and GI oncological indications, today announced ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...